A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects

NCT07422142 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
54
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Kunming Pharmaceuticals, Inc.